Business Development

King Pharmaceuticals is committed to improving and protecting the quality of life through an active program of business development with the following strategic focus:

• In-licensing of new innovative exclusive products, including new chemical entities, in late-stage development (Phase II and III);
• Acquisition of approved branded products with strong growth potential;
• Partnerships, strategic alliances and research and development collaborations involving early-stage compounds

King's business development activities are focused on specialty driven markets, particularly:

• Neuroscience
• Hospital
• Acute Care Medicines

The Company also considers compelling strategic opportunities related to other therapeutic categories. If you are interested in presenting a business development proposal to King Pharmaceuticals, please send your expression of interest in writing to:

King Business Development
King Pharmaceuticals, Inc.
400 Crossing Boulevard
Bridgewater, NJ 08807
Fax: (908) 927-8428